Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on August 1, 2007
[Molecular Cancer Therapeutics, 10.1158/1535-7163.MCT-06-0801]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow All Versions of this Article:
1535-7163.MCT-06-0801v1
6/8/2271    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, J. T.-C.
Right arrow Articles by Cheng, A.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, J. T.-C.
Right arrow Articles by Cheng, A.-J.

Research Articles: Therapeutics, Targets, and Development

Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15

Joseph Tung-Chieh Chang 1, Shih-Hsuan Chan , Chien-Yu Lin , Ting-Yang Lin , Hung-Ming Wang , Chun-Ta Liao , Tzu-Hao Wang , Li-Yu Lee , Ann-Joy Cheng *

1 1Department of Radiation Oncology, 2Division of Hematology/Oncology, Department of Internal Medicine, 3Head and Neck Surgery Section, Department of Otorhinolaryngology, 4Genomic Medicine Research Core Laboratory, 5Department of Obstetrics and Gynecology, 6Department of Pathology, Chang Gung Memorial Hospital, and 7Department of Medical Biotechnology, Chang Gung University, Taoyuan, Taiwan

* To whom correspondence should be addressed. E-mail: ajchen{at}mail.cgu.edu.tw.


   Abstract

Radiotherapy is the major treatment modality for nasopharyngeal cancer (NPC), but in some cases, the disease is radioresistant. We designed this study to identify genes that may be involved in this resistance. We first established two radioresistant subclone cell lines derived from NPC parental cell lines (NPC-076 and NPC-BM1) by treating the cells with four rounds of sublethal ionizing radiation. cDNA microarray analysis was then done, comparing the two resistant cell lines with their corresponding parental cell lines. Seven genes were found to be up-regulated in radioresistant subclones, including gp96 and GDF15, which had shown highest overexpressions. We constructed small interfering RNA plasmids (gp96si and GDF15si) and transfected them into NPC cells to knock down these genes and examine whether this changed their response to radiation. Both gp96si and GDF15si transfectants had radiation-induced growth delay and reduction in colonogenic survival compared with control cells. Knockdown of either gp96 or GDF15 increased the proportion of the cells in G2-M phase, the most radiosensitive phase of the cell cycle. We have therefore identified at least two genes, gp96 and GDF15, involved in radioresistance of NPC cell lines and showed that knockdown of the genes enhances radiosensitivity. [Mol Cancer Ther 2007;6(8):2271–9]

Key Words: radioresistance gene, nasopharyngeal cancer, gp96, GDF15, microarray







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.